Skip to content
10-K

Annual Report

SIGNPATH PHARMA, INC.

0001096906-14-000420

← back to feed
Filed
Mar 31, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Mar 28, 2014 12.88M sh
Capex FY 2013 · Dec 31, 2013 $5.39K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$5.95M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$883.33K
Sga Expense FY 2013 · Dec 31, 2013 $1.3M
Sga Expense FY 2013 · Dec 31, 2012 $45.6K
Rd Expense FY 2013 · Dec 31, 2013 $4.3M
Rd Expense restated FY 2013 · Dec 31, 2012 $939.3K
Net Income FY 2013 · Dec 31, 2013 −$10.67M
Net Income FY 2013 · Dec 31, 2012 −$1.31M
Net Income FY 2013 · Dec 31, 2011 −$2.28M
Net Income FY 2013 · Dec 31, 2010 −$2.12M
Net Income FY 2013 · Dec 31, 2009 −$730.74K
Net Income FY 2013 · Dec 31, 2008 −$1.7M
Net Income FY 2013 · Dec 31, 2007 −$526.83K
Operating Income FY 2013 · Dec 31, 2013 −$9.7M
Operating Income restated FY 2013 · Dec 31, 2012 −$1.31M
Current Liabilities restated FY 2013 · Dec 31, 2012 $6.58M
Current Assets FY 2013 · Dec 31, 2012 $31.92K
Total Assets FY 2013 · Dec 31, 2012 $32.07K
Stockholders Equity restated FY 2013 · Dec 31, 2011 −$5.85M
Stockholders Equity restated FY 2013 · Dec 31, 2010 −$4.4M
Stockholders Equity restated FY 2013 · Dec 31, 2009 −$2.64M
Stockholders Equity restated FY 2013 · Dec 31, 2008 $107.33K
Stockholders Equity FY 2013 · Dec 31, 2007 −$297.96K
Stockholders Equity FY 2013 · Dec 31, 2006 $10K